Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself
- 25 November 2005
- journal article
- editorial material
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 97 (11), e97-103
- https://doi.org/10.1161/01.res.0000193595.03608.08
Abstract
Intravenous administration to human volunteers of a commercial preparation of recombinant human C-reactive protein (CRP) produced in Escherichia coli was recently reported in this journal to induce an acute phase response of serum amyloid A protein (SAA) and of CRP itself, and to activate the coagulation system. The authors concluded that CRP is probably a mediator of atherothrombotic disease. Here we confirm that this recombinant CRP preparation was proinflammatory both for mouse macrophages in vitro and for mice in vivo, but show that pure natural human CRP had no such activity. Furthermore mice transgenic for human CRP, and expressing it throughout their lives, maintained normal concentrations of their most sensitive endogenous acute phase reactants, SAA and serum amyloid P component (SAP). The patterns of in vitro cytokine induction and of in vivo acute phase stimulation by the recombinant CRP preparation were consistent with contamination by bacterial products, and there was 46.6 EU of apparent endotoxin activity per mg of CRP in the bacterial product, compared with 0.9 EU per mg of our isolated natural human CRP preparation. The absence of any proinflammatory activity in natural CRP for macrophages or healthy mice strongly suggests that the in vivo effects of the recombinant preparation observed in humans were attributable to proinflammatory bacterial products and not human CRP.Keywords
This publication has 54 references indexed in Scilit:
- C-reactive protein does not relax vascular smooth muscle: effects mediated by sodium azide in commercially available preparationsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Evidence for Sodium Azide as an Artifact Mediating the Modulation of Inducible Nitric Oxide Synthase by C-Reactive ProteinJournal of Cardiovascular Pharmacology, 2005
- Letter Regarding Article by Li et al, “C-Reactive Protein Upregulates Complement-Inhibitory Factors in Endothelial Cells”Circulation, 2004
- Human C-Reactive Protein Increases Cerebral Infarct Size after Middle Cerebral Artery Occlusion in Adult RatsJournal of Cerebral Blood Flow & Metabolism, 2004
- Poor Predictive Value of High-Sensitivity C-Reactive Protein Indicates Need for ReassessmentClinical Chemistry, 2004
- Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatientAge and Ageing, 1997
- Detection of endotoxin in mice by measurement of endotoxin-induced changes in plasma concentrations of zinc and of the acute-phase protein serum amyloid P-componentJournal of Pharmacy and Pharmacology, 1986
- Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins.The Journal of Experimental Medicine, 1984
- C-REACTIVE PROTEIN FIFTY YEARS ONThe Lancet, 1981
- Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Molecular size as a determinant of plasma lipoprotein influx.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1981